Literature DB >> 15958111

Prioritizing health-care funding.

J L O'Donnell1, D Smyth, C Frampton.   

Abstract

In the face of limited resources, on what basis should we prioritize health-care funding? The most influential consideration should be the knowledge that an intervention does something beneficial for the person who receives it. Rather than using imposed knowledge or knowledge obtained by grace, modern medicine uses knowledge obtained by rational thought. Traditionally, two philosophical schools of rational thought support medical interventions: empiricism and rationalism. Empiricist knowledge underpins the treatment of risk, while rationalist knowledge underpins the treatment of disease. To introduce reasoned order into the rationing process we must understand the limitations inherent in the application of these two forms of knowledge. Why are screening programmes for breast and uterine cervical cancer supported while severe restrictions are placed on treatments for chronic arthritis? Can the benefits of cholesterol-lowering drugs be measured? Empiricism has achieved an unchallenged ascendancy in modern health-care delivery. Is this ascendancy justified? There is a need for reference criteria to compare the benefits of competing interventions across disciplines. As a starting point for debate we propose that interventions should be given a priority based on how closely they fulfil five criteria: knowledge of disease pathophysiology, measurability of short-term and long-term benefits, incidence of serious adverse effects and affordability. It is only by using and refining such funding criteria that better public understanding of the rationing process will be achieved and political interference minimized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958111     DOI: 10.1111/j.1445-5994.2005.00839.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  8 in total

1.  Prevention and clinical complexity.

Authors:  Juan Gérvas; Iona Heath; Antonio Durán; Joan Gené
Journal:  Aten Primaria       Date:  2009-05-21       Impact factor: 1.137

Review 2.  Societal values in the allocation of healthcare resources: is it all about the health gain?

Authors:  Tania Stafinski; Devidas Menon; Deborah Marshall; Timothy Caulfield
Journal:  Patient       Date:  2011       Impact factor: 3.883

Review 3.  Health technology funding decision-making processes around the world: the same, yet different.

Authors:  Tania Stafinski; Devidas Menon; Donald J Philippon; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

Review 4.  Acute kidney injury clinical trial design: old problems, new strategies.

Authors:  Zoltán H Endre; John W Pickering
Journal:  Pediatr Nephrol       Date:  2012-05-26       Impact factor: 3.714

5.  Musculoskeletal disorders: epidemiology and treatment seeking behavior of secondary school students in a nigerian community.

Authors:  Adegbehingbe Olayinka O; Fatusi Adesegun O; Adegbenro Caleb A; Late Adeitan Opeyemi O; Abass Ganiyu O; Akintunde Akintomiwa
Journal:  Indian J Community Med       Date:  2009-01

6.  Combating disease mongering: daunting but nonetheless essential.

Authors:  Iona Heath
Journal:  PLoS Med       Date:  2006-04-11       Impact factor: 11.069

7.  Musculoskeletal disorders: epidemiology and treatment seeking behavior of secondary school students in a nigerian community.

Authors:  Olayinka O Adegbehingbe; Adesegun O Fatusi; Caleb A Adegbenro; Opeyemi O Adeitan; Ganiyu O Abass; Akintomiwa O Akintunde
Journal:  Indian J Community Med       Date:  2009-04

8.  Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care.

Authors:  Richard J Epstein
Journal:  BMC Cancer       Date:  2007-05-30       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.